WHO drug trial for COVID-19
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time

The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients